Vanda Pharmaceuticals Inc (USD)
VNDA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range17.21 | 17.62
52-Wk Range11.83 | 31.30
Last Close17.11
Mkt Cap (m)912.60
Dividend yield-
ISINUS9216591084
Volume272,820
Exchange VenueNAS

Company Profile

Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

Key Information
Price/Earning7.67
Price/Book2.28
Price/Sales4.28
P/CF18.27
Rev Growth (3 year avg)20.66
EPS Growth (3 year avg)-
Operating Margin % 11.26
Net Margin %13.05
Return on Equity12.39
Debt/Equity-

Legal Documents

Prospectus
en 16/03/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)3450110146165193
Operating Income (m)-20-58-40-19-1722
Net Income (m)-2020-40-18-1625
Basic EPS-0.670.58-0.94-0.41-0.350.50
Avg. Diluted Shares Outstanding (m)303742434553
Balance Sheet
USD201320142015201620172018
Current Assets (m)136142167174170299
Non Current Assets (m)83047363633
Total Assets (m)143172213210205332
Current Liabilities (m)33851507053
Total Liabilities (m)------
Total Equity (m)44161133131131275
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-40-8212-8-230
Capital Expenditure (m)-9-3-1-2-25
Figures are quoted in USD unless stated otherwise
0.22 (1.26%)
$
17.33
Last Price